These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 32641006)

  • 1. Prevalence of HBV and HCV infections, Bhutan, 2017: Progress and next steps.
    Tshering N; Dhakal GP; Wangchuk U; Wangdi S; Khandu L; Pelden S; Nogareda F; Patel MK; Hutin YJF; Wannemuehler K; Rewari BB; Wangchuk S
    BMC Infect Dis; 2020 Jul; 20(1):485. PubMed ID: 32641006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in Morocco.
    Baha W; Foullous A; Dersi N; They-they TP; El alaoui K; Nourichafi N; Oukkache B; Lazar F; Benjelloun S; Ennaji MM; Elmalki A; Mifdal H; Bennani A
    BMC Public Health; 2013 Jan; 13():50. PubMed ID: 23331910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hepatitis B virus infection among health care workers in a tertiary hospital in Tanzania.
    Mueller A; Stoetter L; Kalluvya S; Stich A; Majinge C; Weissbrich B; Kasang C
    BMC Infect Dis; 2015 Sep; 15():386. PubMed ID: 26399765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents.
    Papa A; Felice C; Marzo M; Andrisani G; Armuzzi A; Covino M; Mocci G; Pugliese D; De Vitis I; Gasbarrini A; Rapaccini GL; Guidi L
    J Crohns Colitis; 2013 Mar; 7(2):113-9. PubMed ID: 22464811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of hepatitis B and C and relationship to liver damage in HIV infected patients attending Joint Clinical Research Centre Clinic (JCRC), Kampala, Uganda.
    Baseke J; Musenero M; Mayanja-Kizza H
    Afr Health Sci; 2015 Jun; 15(2):322-7. PubMed ID: 26124775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of hepatitis B virus and hepatitis C virus infection among pregnant women attending antenatal care at Guhala Primary Hospital, Northwestern Ethiopia.
    Belete D; Fekadie E; Kassaw M; Fenta M; Jegnie A; Mulu T; Adane G; Abebe W; Amare A
    BMC Pregnancy Childbirth; 2024 Jul; 24(1):512. PubMed ID: 39075410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and trends of hepatitis B and C virus biomarkers in Zimbabwe: comparative analyses of a nation's blood-donor surveillance data and meta-analyses of population studies.
    Mabaya S; Munongo E; Mapako T; Marowa L; Gasasira AN; Pasipanodya JG; Mutenherwa M
    Infect Dis (Lond); 2024 Sep; 56(9):759-775. PubMed ID: 38743051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hepatitis B and C markers in a population of an urban university in Rio de Janeiro, Brazil: a cross-sectional study.
    Pinto FP; Ferreira OC; Olmedo DB; Precioso PM; Barquette FR; Castilho MC; Silva SG; Pôrto LC
    Ann Hepatol; 2015; 14(6):815-25. PubMed ID: 26436353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk factors of hepatitis B and C virus infections in an impoverished urban community in Dhaka, Bangladesh.
    Ashraf H; Alam NH; Rothermundt C; Brooks A; Bardhan P; Hossain L; Salam MA; Hassan MS; Beglinger C; Gyr N
    BMC Infect Dis; 2010 Jul; 10():208. PubMed ID: 20630111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The changing epidemiology of hepatitis B and C infections in Nanoro, rural Burkina Faso: a random sampling survey.
    Lingani M; Akita T; Ouoba S; Nagashima S; Boua PR; Takahashi K; Kam B; Sugiyama A; Nikiema T; Yamamoto C; Somé A; Derra K; Ko K; Sorgho H; Tarnagda Z; Tinto H; Tanaka J
    BMC Infect Dis; 2020 Jan; 20(1):46. PubMed ID: 31941454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation program.
    Peto TJ; Mendy ME; Lowe Y; Webb EL; Whittle HC; Hall AJ
    BMC Infect Dis; 2014 Jan; 14():7. PubMed ID: 24397793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sero-prevalence of hepatitis B virus markers and associated factors among children in Hawassa City, southern Ethiopia.
    Argaw B; Mihret A; Aseffa A; Tarekegne A; Hussen S; Wachamo D; Shimelis T; Howe R
    BMC Infect Dis; 2020 Jul; 20(1):528. PubMed ID: 32698884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and associated risk factors for hepatitis B and C viruses among refugee populations living in Mahama, Rwanda: A cross-sectional study.
    Kamali I; Barnhart DA; Ndahimana JD; Noor K; Mumporeze J; Nyirahabihirwe F; Gakuru JP; Musafiri T; Urusaro S; Makuza JD; Serumondo J; Rwamuhinda DD; Nkundibiza M; Kateera F; Nshogoza GR; Mubiligi JM
    PLoS One; 2021; 16(10):e0257917. PubMed ID: 34634039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults.
    Wang Y; Chen T; Lu LL; Wang M; Wang D; Yao H; Fan C; Qi J; Zhang Y; Qu C
    Vaccine; 2017 Feb; 35(7):1064-1070. PubMed ID: 28069363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HBV and HCV infection in Japanese dental care workers.
    Nagao Y; Matsuoka H; Kawaguchi T; Ide T; Sata M
    Int J Mol Med; 2008 Jun; 21(6):791-9. PubMed ID: 18506374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
    Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
    Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus infection among pregnant women in Haiti: A cross-sectional serosurvey.
    Tohme RA; Andre-Alboth J; Tejada-Strop A; Shi R; Boncy J; François J; Domercant JW; Griswold M; Hyppolite E; Adrien P; Kamili S
    J Clin Virol; 2016 Mar; 76():66-71. PubMed ID: 26851543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017).
    Scheibe A; Young K; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Puren A; Hausler H
    BMC Infect Dis; 2020 Sep; 20(1):655. PubMed ID: 32894072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B and C infection: is it a problem in Polish healthcare workers?
    Rybacki M; Piekarska A; Wiszniewska M; Walusiak-Skorupa J
    Int J Occup Med Environ Health; 2013 Jun; 26(3):430-9. PubMed ID: 23817869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cross-sectional epidemiological study of HBV, HCV, HDV and HEV prevalence in the SubCarpathian and South-Eastern regions of Romania.
    Voiculescu M; Iliescu L; Ionescu C; Micu L; Ismail G; Zilisteanu D; Radasan A; Micu G; Pertache I
    J Gastrointestin Liver Dis; 2010 Mar; 19(1):43-8. PubMed ID: 20361074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.